INVO Bioscience (INVO) Tops Q3 EPS by $1.50

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. ABBV
5. AAPL
6. MRVL
7. CL
8. TFII
9. LYB
10. RXRX

Go back to INVO Bioscience (INVO) Tops Q3 EPS by $1.50

INVO Reports Record Third Quarter 2023 Financial Results

November 13, 2023 4:01 PM EST

Company Expects to Host Conference Call Shortly After November 20, 2023 Following the Progress of Certain Closing Conditions Pertaining to the Announced Merger Agreement with NAYA Biosciences

SARASOTA, Fla., Nov. 13, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture ("IVC") procedure it enables, today announced financial results for the third quarter ended September 30, 2023 and provided a business... More